BioSpace News Archive

Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company has completed the first phase of development with a medical partner located in the USA, to build a customized head mounted display system for assisted medical cancer surgery

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1 st , 2020, for its clinical stage autologous Natural Killer (“NK”) cell therapy and companion diagnostic platform, for all fields worldwide. The autologous NK cell therapy redirects a patient’s NK cells to target a cell membrane form of Heat Shock Protein 70 (Hsp70) which has been discov

Although widely used in manufacturing, robots require much more agility for use in nursing and rehabilitation.

Oklahoma Complete Health, a wholly-owned subsidiary of Centene Corporation, announced the appointment of Clay Franklin as Plan President and Chief Executive Officer.

Bayer and the National Kidney Foundation (NKF) today announced that award-winning actress, Debbie Allen, has joined the “Are You the 33%?” national public awareness campaign to focus attention on the increased risk of developing chronic kidney disease (CKD), also referred to as kidney disease, in people with type 2 diabetes (T2D).

A new report from the Pharmaceutical Research and Manufacturers of America uncovers the system of incentives that lead hospitals to drive up costs for patients and employers by marking up the price of medicines.

The Diagnostic imaging team at McMaster University Hospital was concerned about the ultrasound technologists’ lack of protection whilst sitting to the side of patients.

Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company’s management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021.

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financial results for the fiscal 2021 second quarter ended December 31, 2020